← Search & browse all drugs
CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › CARDIAC GLYCOSIDES › Digitalis glycosides
digitalis leaves
C01AA03
Forms & Strengths
- Digitalis leaf powder oral tablets: 100 mg
- Digitalis leaf powder oral tablets: 81 mg (1.25 grains)
Adult Dosing
- Digitalization (Rapid): 0.8 to 1.2 g orally divided over 24 hours
- Digitalization (Slow): 0.1 to 0.2 g daily for several days until digitalization is achieved
- Maintenance: 50 to 100 mg orally once daily
Pediatric Dosing
- Safety and efficacy not well established in pediatric patients
- Use generally discouraged in favor of purified cardiac glycosides like digoxin
Indications
- Congestive heart failure
- Atrial fibrillation (rate control)
- Atrial flutter
- Paroxysmal atrial tachycardia
Mechanism of Action
- Inhibits myocardial Na+/K+-ATPase membrane pump
- Increases intracellular sodium, leading to increased intracellular calcium via Na+/Ca2+ exchanger
- Enhances myocardial contractility (positive inotrope)
- Decreases conduction velocity and increases effective refractory period through vagal stimulation (negative chronotrope)
Contraindications
- Ventricular fibrillation
- Ventricular tachycardia
- Digitalis-induced toxicity
- Second- or third-degree atrioventricular block without a pacemaker
- Wolff-Parkinson-White syndrome with pre-excitation
- Hypertrophic cardiomyopathy with outflow obstruction
Adverse Reactions
- Nausea and vomiting
- Anorexia
- Visual disturbances (blurred vision, yellow-green halos)
- Cardiac arrhythmias (premature ventricular contractions, bradycardia, heart block)
- Confusion and dizziness
- Gynecomastia with chronic use
Drug Interactions
- Loop and thiazide diuretics causing hypokalemia and hypomagnesemia, increasing toxicity risk
- Quinidine, verapamil, and amiodarone increasing serum levels by reducing clearance
- Sympathomimetics and beta-agonists increasing risk of cardiac arrhythmias
- Antacids and cholestyramine decreasing GI absorption of digitalis
Curated Content: Needs Vetting Before Put to Clinical Use